Get the tools used by (smart)2 investors.
SP500 -0.3%DOW -0.5%FTSE 100 0.5%NIKKEI -0.3%OIL -0.4%GOLD -0.3%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Predicted Market Cap / Fwd FFO (FY+2) for Intracellular Th

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ITCI: Intracellular Th

Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in psych...

131.95 USD
Price
– USD
Fair Value
–
Upside
64.09 - 131.95
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

How does Intracellular Th's Predicted Market Cap / Fwd FFO (FY+2) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Intracellular Th because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Intracellular Th Predicted Market Cap / Fwd FFO (FY+2) Benchmarks
NameTickerPredicted Market Cap / Fwd FFO (FY+2)
Intracellular ThNASDAQGS:ITCI0.0x
HealthcareSECTOR:HLTH.US0.0x
ANI Pharmaceuticals IncNASDAQGM:ANIP0.0x
Viatris IncNASDAQGS:VTRS0.0x
Eli Lilly and CompanyNYSE:LLY0.0x
Teva Pharmaceutical Industries LimitedOTCPK:TEVJ.F0.0x
Pfizer IncNYSE:PFE0.0x
Bristol-Myers Squibb CompanyNYSE:BMY0.0x
Luye Pharma Group Ltd.OTCPK:LYPH.F0.0x
Sumitomo Pharma Co., Ltd.OTCPK:DNPU.F0.0x
Vanda Pharmaceuticals IncNASDAQGM:VNDA0.0x
AstraZeneca PLC ADRNASDAQGS:AZN0.0x

Metric Usage: Predicted Market Cap / Fwd FFO (FY+2)

Hide this widget
prediction_market_to_ffo_fwd2
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Predicted Market Cap / Fwd FFO (FY+2) in the predictions category include:

  • DDM Fair Value Upside - Our estimate of fair value upside for a company using various dividend discount models.
  • Predicted Price / LTM Sales Ratio - Our estimate of the fair value Price / LTM Sales Ratio for a company.
  • Analyst Price Target Mean - The mean or average analyst price target for a stock. Price targets represent what analysts believe a stock will be worth within the next 12 to 18 months.
  • DCF Fair Value - Our estimate of fair value for a company using various discounted cash flow analysis methods.
View Full List

Search for metric or datapoint

Predicted Market Cap / Fwd FFO (FY+2)

Our estimate of the fair value Market Cap / Fwd FFO (FY+2) for a REIT.

Definition of Predicted Market Cap / Fwd FFO (FY+2)

Hide this widget
Our estimate of the fair value Market Cap / Fwd FFO (FY+2) for a REIT.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0.0x0.3x0.5x0.8x1.0x01,0002,000

The chart above depicts the distribution of predicted market cap / fwd ffo (fy+2) for companies operating in the Healthcare sector in the Developed economic region. Over 2,470 companies were considered in this analysis, and 2,478 had meaningful values. The average predicted market cap / fwd ffo (fy+2) of companies in the sector is 0.0x with a standard deviation of 0.0x.

Intracellular Th's Predicted Market Cap / Fwd FFO (FY+2) of 0.0x ranks in the 0.0% percentile for the sector. The following table provides additional summary stats:

Predicted Market Cap / Fwd FFO (FY+2) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,479
Included Constituents2,478
Min0.0x
Max0.0x
Median0.0x
Mean0.0x
Standard Deviation0.0x

You can find companies with similar predicted market cap / fwd ffo (fy+2) using this stock screener.

All rights reserved. Terms Of Use